Literature DB >> 15312142

TLR9-/- and TLR9+/+ mice display similar immune responses to a DNA vaccine.

Shawn Babiuk1, Neeloffer Mookherjee, Reno Pontarollo, Phillip Griebel, Sylvia van Drunen Littel-van den Hurk, Rolf Hecker, Lorne Babiuk.   

Abstract

Plasmid DNA continues to attract interest as a potential vaccine-delivery vehicle. However, the mechanisms whereby immune responses are elicited by plasmids are not fully understood. Although there have been suggestions regarding the importance of CpG motifs in plasmid immunogenicity, the molecular mechanisms by which CpG motifs enhance immune responses to DNA vaccines are not well understood. As Toll-like receptor 9-deficient (TLR9-/-) mice fail to respond to the adjuvant effects of CpG oligonucleotides, we used these mice to determine the effect of CpG motifs in plasmids used for DNA immunization. In the study described below, we report that DNA immunization was as effective in eliciting antigen-specific antibody and at stimulating antigen-specific interferon-gamma (IFN-gamma)-secreting cells in TLR9-/- mice as in TLR9+/+ mice. This study illustrates that DNA vaccines elicit immune responses by multiple mechanisms and demonstrates that TLR9 is not essential for the induction of immune responses following DNA immunization.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15312142      PMCID: PMC1782555          DOI: 10.1111/j.1365-2567.2004.01938.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  28 in total

1.  Effects of intradermally administered plasmid deoxyribonucleic acid on ovine popliteal lymph node morphology.

Authors:  R R Uwiera; R Rankin; G P Adams; R Pontarollo; S van Drunen Littel-van den Hurk; D M Middleton; L A Babiuk; P J Griebel
Journal:  Anat Rec       Date:  2001-02-01

Review 2.  Recent advances in the use of DNA vaccines for the treatment of diseases of farmed animals.

Authors:  S van Drunen Littel-van den Hurk; V Gerdts; B I Loehr; R Pontarollo; R Rankin; R Uwiera; L A Babiuk
Journal:  Adv Drug Deliv Rev       Date:  2000-09-15       Impact factor: 15.470

3.  Augmentation of cellular immune responses to bovine herpesvirus-1 glycoprotein D by vaccination with CpG-enhanced plasmid vectors.

Authors:  R A Pontarollo; L A Babiuk; R Hecker; S van Drunen Littel-van den Hurk
Journal:  J Gen Virol       Date:  2002-12       Impact factor: 3.891

4.  Increased DNA vaccine delivery and immunogenicity by electroporation in vivo.

Authors:  G Widera; M Austin; D Rabussay; C Goldbeck; S W Barnett; M Chen; L Leung; G R Otten; K Thudium; M J Selby; J B Ulmer
Journal:  J Immunol       Date:  2000-05-01       Impact factor: 5.422

5.  Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition.

Authors:  S Bauer; C J Kirschning; H Häcker; V Redecke; S Hausmann; S Akira; H Wagner; G B Lipford
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-24       Impact factor: 11.205

6.  Co-expression of granulocyte-macrophage colony-stimulating factor with antigen enhances humoral and tumor immunity after DNA vaccination.

Authors:  Xiangle Sun; Lisa M Hodge; Harlan P Jones; Leslie Tabor; Jerry W Simecka
Journal:  Vaccine       Date:  2002-01-31       Impact factor: 3.641

7.  Multiple effects of codon usage optimization on expression and immunogenicity of DNA candidate vaccines encoding the human immunodeficiency virus type 1 Gag protein.

Authors:  L Deml; A Bojak; S Steck; M Graf; J Wild; R Schirmbeck; H Wolf; R Wagner
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

8.  Adjuvant effect of multi-CpG motifs on an HIV-1 DNA vaccine.

Authors:  Yoshitsugu Kojima; Ke-Qin Xin; Takaaki Ooki; Kenji Hamajima; Tomohiro Oikawa; Kaori Shinoda; Tomomi Ozaki; Yuka Hoshino; Nao Jounai; Masatoshi Nakazawa; Dennis Klinman; Kenji Okuda
Journal:  Vaccine       Date:  2002-07-26       Impact factor: 3.641

9.  The immunogenicity and protective efficacy of bovine herpesvirus 1 glycoprotein D plus Emulsigen are increased by formulation with CpG oligodeoxynucleotides.

Authors:  X P Ioannou; P Griebel; R Hecker; L A Babiuk; S van Drunen Littel-van den Hurk
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

10.  DNA-based vaccination against hepatitis C virus (HCV): effect of expressing different forms of HCV E2 protein and use of CpG-optimized vectors in mice.

Authors:  Xiaoying Ma; Xavier Forns; Robin Gutierrez; Isa K Mushahwar; Tong Wu; Paul J Payette; Jens Bukh; Robert H Purcell; Heather L Davis
Journal:  Vaccine       Date:  2002-09-10       Impact factor: 3.641

View more
  26 in total

Review 1.  Nucleic acid sensing receptors in systemic lupus erythematosus: development of novel DNA- and/or RNA-like analogues for treating lupus.

Authors:  P Lenert
Journal:  Clin Exp Immunol       Date:  2010-05-07       Impact factor: 4.330

Review 2.  Nucleic acid sensing at the interface between innate and adaptive immunity in vaccination.

Authors:  Christophe J Desmet; Ken J Ishii
Journal:  Nat Rev Immunol       Date:  2012-06-22       Impact factor: 53.106

3.  Single chain MHC I trimer-based DNA vaccines for protection against Listeria monocytogenes infection.

Authors:  Sojung Kim; Adam Zuiani; Javier A Carrero; Ted H Hansen
Journal:  Vaccine       Date:  2012-01-26       Impact factor: 3.641

4.  Plasmid vector-linked maturation of natural killer (NK) cells is coupled to antigen-dependent NK cell activation during DNA-based immunization in mice.

Authors:  Ren Zhu; Maryline Mancini-Bourgine; Xiao Ming Zhang; Florence Bayard; Qiang Deng; Marie-Louise Michel
Journal:  J Virol       Date:  2011-07-20       Impact factor: 5.103

Review 5.  DNA vaccines for prostate cancer.

Authors:  Christopher D Zahm; Viswa Teja Colluru; Douglas G McNeel
Journal:  Pharmacol Ther       Date:  2017-02-07       Impact factor: 12.310

6.  Essential role for TLR9 in prime but not prime-boost plasmid DNA vaccination to activate dendritic cells and protect from lethal viral infection.

Authors:  Diane Rottembourg; Christophe M Filippi; Damien Bresson; Katrin Ehrhardt; Elizabeth A Estes; Janine E Oldham; Matthias G von Herrath
Journal:  J Immunol       Date:  2010-05-07       Impact factor: 5.422

7.  Optimization of the immunogenicity of a DNA vaccine encoding a bacterial outer membrane lipoprotein.

Authors:  Arun Buaklin; Tanapat Palaga; Drew Hannaman; Ruthairat Kerdkaew; Kanitha Patarakul; Alain Jacquet
Journal:  Mol Biotechnol       Date:  2014-10       Impact factor: 2.695

8.  Identification of Aim2 as a sensor for DNA vaccines.

Authors:  John J Suschak; Shixia Wang; Katherine A Fitzgerald; Shan Lu
Journal:  J Immunol       Date:  2014-12-08       Impact factor: 5.422

9.  Innate immune recognition of nucleic acids.

Authors:  Tsan Xiao
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

10.  Contribution of IRF-3 mediated IFNbeta production to DNA vaccine dependent cellular immune responses.

Authors:  Hidekazu Shirota; Lev Petrenko; Toshio Hattori; Dennis M Klinman
Journal:  Vaccine       Date:  2009-02-10       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.